Related references
Note: Only part of the references are listed.Management of cutaneous manifestations of lupus erythematosus: A systematic review
J. L. Fairley et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches
Maria Cristina Petralia et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
The Role of Macrophage Migration Inhibitory Factor in Alzheimer ' s Disease: Conventionally Pathogenetic or Unconventionally Protective?
Maria Cristina Petralia et al.
MOLECULES (2020)
The Dichotomic Role of Macrophage Migration Inhibitory Factor in Neurodegeneration
Maria Sofia Basile et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
Eugenio Cavalli et al.
MOLECULES (2020)
Psoriasis and Connective Tissue Diseases
Toshiyuki Yamamoto
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair
Laura Farr et al.
FRONTIERS IN IMMUNOLOGY (2020)
An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice
Jay Patel et al.
CURRENT RHEUMATOLOGY REPORTS (2020)
Macrophage Migration Inhibitory Factor Regulates U1 Small Nuclear RNP Immune Complex-Mediated Activation of the NLRP3 Inflammasome
Min Sun Shin et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection
Amanguli Ruze et al.
CLINICAL SCIENCE (2019)
Evolving complexity of MIF signaling
Stanislovas S. Jankauskas et al.
CELLULAR SIGNALLING (2019)
Rediscovering MIF: New Tricks for an Old Cytokine
James Harris et al.
TRENDS IN IMMUNOLOGY (2019)
Immunohistochemical Expression of ABCB5 as a Potential Prognostic Factor in Uveal Melanoma
Giuseppe Broggi et al.
APPLIED SCIENCES-BASEL (2019)
Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
Laura Soumoy et al.
CANCERS (2019)
Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
Maria Cristina Petralia et al.
MOLECULES (2019)
The immunobiology of MIF: function, genetics and prospects for precision medicine
Insoo Kang et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS
Marcel F. Leyton-Jaimes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression
Maria Cristina Petralia et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis
Eugenio Cavalli et al.
MEDICINA-LITHUANIA (2019)
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets
Maria Sofia Basile et al.
FRONTIERS IN ONCOLOGY (2019)
Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma
Eugenio Cavalli et al.
BRAIN SCIENCES (2019)
Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets
Sven Gunther et al.
DRUG DISCOVERY TODAY (2019)
Differential modulation and prognostic values of immune-escape genes in uveal melanoma
Maria Sofia Basile et al.
PLOS ONE (2019)
MIF promotes a differential Thl/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients
Ulises De la Cruz-Mosso et al.
CELLULAR IMMUNOLOGY (2018)
Emerging immune targets for the treatment of multiple myeloma
Atif Sohail et al.
IMMUNOTHERAPY (2018)
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences
Paolo Fagone et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery
Christian Stoppe et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS
Neta Shvil et al.
CELL DEATH & DISEASE (2018)
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma
Mario Presti et al.
ONCOLOGY LETTERS (2018)
Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation
Tali Lang et al.
NATURE COMMUNICATIONS (2018)
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis
Santa Mammana et al.
Oncotarget (2018)
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
Katia Mangano et al.
Oncotarget (2018)
Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
Carlos R. Figueiredo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
R. J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review
Jerome R. Lechien et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
MIF and D-DT are potential disease severity modifiers in male MS subjects
Gil Benedek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Drugs for discoid lupus erythematosus
Sue Jessop et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Macrophage Migration Inhibitory Factor as a Chaperone Inhibiting Accumulation of Misfolded SOD1
Adrian Israelson et al.
NEURON (2015)
Macrophage migration inhibitory factor has a permissive role in concanavalin A-induced cell death of human hepatoma cells through autophagy
Y-C Lai et al.
CELL DEATH & DISEASE (2015)
MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus
Tali Lang et al.
FRONTIERS IN IMMUNOLOGY (2015)
Dominant Th1 and Minimal Th17 Skewing in Discoid Lupus Revealed by Transcriptomic Comparison with Psoriasis
Ali Jabbari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Inactivation of Tautomerase Activity of Macrophage Migration Inhibitory Factor by Sulforaphane: a Potential Biomarker for Anti-inflammatory Intervention
Zachary R. Healy et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
MIF: a key player in cutaneous biology and wound healing
Stephen C. Gilliver et al.
EXPERIMENTAL DERMATOLOGY (2011)
MIF in autoimmunity and novel therapeutic approaches
Stanislava Stosic-Grujicic et al.
AUTOIMMUNITY REVIEWS (2009)
Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart
Edward J. Miller et al.
NATURE (2008)
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis
F Nicoletti et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Cutaneous lupus erythematosus
DP McCauliffe
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2001)
Share Paper
